Michal Bitman
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Oncology 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Zdeněk Dvořák (6 shared papers)Radim Vrzal (6 shared papers)Petr Pávek (6 shared papers)Lucie Krausová (2 shared papers)Lucie Stejskalová (2 shared papers)J Blahoš (1 shared paper)Petr Bachleda (1 shared paper)Tomáš Smutný (1 shared paper)
- Journals
- Toxicology Letters (2 papers)Frontiers in Pharmacology (1 paper)Journal of Thrombosis and Haemostasis (1 paper)Archives of Toxicology (1 paper)Biomedical Papers (1 paper)
- Partner nations
- Czechia
In The Last Decade
Michal Bitman
6 papers receiving 456 citations
Michal Bitman's Hit Papers
Peers
Comparison fields: 5 of 97
- Pharmacology 71
- Geriatrics and Gerontology 21
- Biological Psychiatry 7
- Cellular and Molecular Neuroscience 49
- Neurology 21
Countries citing papers authored by Michal Bitman
This map shows the geographic impact of Michal Bitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Bitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Bitman more than expected).
Fields of papers citing papers by Michal Bitman
This network shows the impact of papers produced by Michal Bitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Bitman. The network helps show where Michal Bitman may publish in the future.
Co-authors
The 8 scholars most cited alongside Michal Bitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human Hepatocytes Hit paper breakdown → | 2012 | 345 |
| 2 | 2010 | 46 | |
| 3 | 2010 | 32 | |
| 4 | 2014 | 27 | |
| 5 | 2012 | 5 | |
| 6 | 2011 | 3 |
About Michal Bitman
Michal Bitman is a scholar working on Pharmacology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Pathology and Forensic Medicine, having authored 6 papers that have together received 458 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Pregnancy and Medication Impact (2 papers), Vitamin D Research Studies (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Estrogen and related hormone effects (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Pharmacology (71 citations), Geriatrics and Gerontology (21 citations), Biological Psychiatry (7 citations), Cellular and Molecular Neuroscience (49 citations) and Neurology (21 citations). Michal Bitman has collaborated with scholars based in Czechia. Frequent co-authors include Zdeněk Dvořák, Radim Vrzal, Petr Pávek, Lucie Krausová, Lucie Stejskalová, J Blahoš, Petr Bachleda and Tomáš Smutný. Their work appears in journals such as Toxicology Letters, Frontiers in Pharmacology, Journal of Thrombosis and Haemostasis, Archives of Toxicology and Biomedical Papers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.